REBLOZYL
Live / Registered — Registered (as of 26 Jan 2021)
What this means for you
Registered since 26 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90033523
- Registration number
- 6257051
- Mark type
- Design + words
- Filed
- 02 Jul 2020
- Published for opposition
- 10 Nov 2020
- Registered
- 26 Jan 2021
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of anemia, beta thalassemia, blood disease, cancer
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 26 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Nov 2020 — PUBLISHED FOR OPPOSITION
- 21 Oct 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Oct 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Oct 2020 — ASSIGNED TO EXAMINER
- 24 Aug 2020 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 20 Aug 2020 — ASSIGNED TO LIE
- 03 Aug 2020 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 31 Jul 2020 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 30 Jul 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Jul 2020 — NEW APPLICATION ENTERED